Xiaoli D.
About Xiaoli D.
Xiaoli Du is a Director of Medical Genomics and an ABMGG board-certified clinical laboratory geneticist with extensive experience in genetic diagnosis and research in cellular oncology.
Title: Director of Medical Genomics
Xiaoli Du holds the title of Director of Medical Genomics. In her role, she oversees the genomic operations within a clinical setting, integrating her expertise in molecular genetics and cytogenetics to provide comprehensive genetic diagnostics. Her leadership in the field ensures the effective implementation of genomic technologies in medical practice.
Education and Expertise in Genetics
Xiaoli Du is an ABMGG board certified clinical laboratory geneticist, certified in both clinical molecular genetics and clinical cytogenetics. She completed three years of specialized clinical genetics fellowship training at Cincinnati Children's Hospital Medical Center, focusing on Laboratory Genetics and Genomics. She also holds a PhD in cancer cell biology from Peking Union Medical College, equipping her with deep expertise in the intersection of cancer biology and genetic diagnostics.
Professional Background in Genetic Diagnosis
With eight years of experience in genetic diagnosis across both public and private sectors, Xiaoli Du has a robust background in clinical applications of genomic technologies. Her role involves the diagnosis and management of genetic disorders, leveraging advanced molecular genetic and cytogenetic techniques.
Research Experience in Cellular Oncology
Xiaoli Du has accumulated five years of research experience in cellular oncology at the National Cancer Institute of the NIH. During her tenure, she contributed to significant research projects aimed at understanding the cellular mechanisms of cancer, adding a strong research dimension to her clinical expertise.
Publications in Peer-Reviewed Journals
Xiaoli Du has published 15 articles in high-impact peer-reviewed journals, including Proceedings of the National Academy of Sciences (PNAS), Oncogene, Journal of Molecular Medicine, Gastroenterology, and the American Journal of Medical Genetics. Her publications reflect her contributions to the fields of cancer cell biology and medical genetics, making her a recognized author in these scientific areas.